Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 1-Year Low at $6.82

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $6.82 and last traded at $6.83, with a volume of 511806 shares changing hands. The stock had previously closed at $6.99.

Analyst Ratings Changes

Separately, The Goldman Sachs Group began coverage on shares of Bayer Aktiengesellschaft in a report on Thursday, May 30th. They set a “neutral” rating on the stock. One equities research analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold”.

Bayer Aktiengesellschaft Stock Up 2.1 %

The firm’s 50-day simple moving average is $7.42 and its 200-day simple moving average is $7.76. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.87 and a current ratio of 1.31.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last released its quarterly earnings results on Tuesday, May 14th. The company reported $0.77 earnings per share (EPS) for the quarter. The company had revenue of $14.95 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 6.70% and a positive return on equity of 17.57%. Sell-side analysts predict that Bayer Aktiengesellschaft will post 1.36 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.